Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Yumanity Therapeutics aggregated by PharmaCompass.com.

    Client Virtual Booth

    YUMANITY THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Yumanity Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    790 Memorial Drive, Suite 2C Cambridge, MA 02139
    Telephone
    Telephone
    617-409-5300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.yumanity.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/yumanity-therapeutics
    Twitter
    Twitter
    https://twitter.com/yumanitytx?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Yumanity Declares Special Dividend In Connection with Proposed Asset Sale
    Yumanity Declares Special Dividend In Connection with Proposed Asset Sale

    https://www.globenewswire.com//news-release/2022/12/05/2567286/0/en/Yumanity-Therapeutics-Declares-Special-Dividend-In-Connection-with-Proposed-Asset-Sale-to-Janssen-and-Merger-with-Kineta.html

    GLOBENEWSWIRE
    05 Dec 2022
    Share Share
    Yumanity Therapeutics Reports 3Q 2022 Financial Results
    Yumanity Therapeutics Reports 3Q 2022 Financial Results

    https://www.globenewswire.com/news-release/2022/11/14/2555009/0/en/Yumanity-Therapeutics-Reports-Third-Quarter-2022-Financial-Results-and-Recent-Corporate-Developments.html

    GLOBENEWSWIRE
    14 Nov 2022
    Share Share
    Yumanity Therapeutics Announces Effectiveness of Registration Statement
    Yumanity Therapeutics Announces Effectiveness of Registration Statement

    https://www.globenewswire.com/news-release/2022/11/10/2553838/0/en/Yumanity-Therapeutics-Announces-Effectiveness-of-Registration-Statement-on-Form-S-4-In-Connection-With-Proposed-Asset-Sale-to-Janssen-and-Merger-with-Kineta-Inc.html

    GLOBENEWSWIRE
    10 Nov 2022
    Share Share
    Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4
    Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4

    https://www.globenewswire.com/news-release/2022/08/29/2505759/0/en/Yumanity-Therapeutics-Announces-Filing-of-Registration-Statement-on-Form-S-4-In-Connection-With-Proposed-Asset-Sale-to-Janssen-and-Merger-with-Kineta.html

    GLOBENEWSWIRE
    29 Aug 2022
    Share Share
    Yumanity Therapeutics Reports Second Quarter 2022 Financial Results
    Yumanity Therapeutics Reports Second Quarter 2022 Financial Results

    https://www.globenewswire.com/news-release/2022/08/04/2492847/0/en/Yumanity-Therapeutics-Reports-Second-Quarter-2022-Financial-Results-and-Recent-Corporate-Developments.html

    GLOBENEWSWIRE
    04 Aug 2022
    Share Share
    Yumanity Announces Definitive Agreements for Two Strategic Transactions
    Yumanity Announces Definitive Agreements for Two Strategic Transactions

    https://www.globenewswire.com/news-release/2022/06/06/2456507/0/en/Yumanity-Therapeutics-Announces-Definitive-Agreements-for-Two-Strategic-Transactions.html

    GLOBENEWSWIRE
    06 Jun 2022
    Share Share
    Yumanity Therapeutics Reports First Quarter 2022 Financial Results
    Yumanity Therapeutics Reports First Quarter 2022 Financial Results

    https://www.globenewswire.com/news-release/2022/05/12/2442561/0/en/Yumanity-Therapeutics-Reports-First-Quarter-2022-Financial-Results-and-Recent-Corporate-Developments.html

    GLOBENEWSWIRE
    12 May 2022
    Share Share
    Yumanity Tx Reports Full-Year 2021 Financial Results and Corporate Developments
    Yumanity Tx Reports Full-Year 2021 Financial Results and Corporate Developments

    https://www.globenewswire.com/news-release/2022/03/24/2409903/0/en/Yumanity-Therapeutics-Reports-Full-Year-2021-Financial-Results-and-Recent-Corporate-Developments.html

    GLOBENEWSWIRE
    24 Mar 2022
    Share Share
    Yumanity to cut 60% of workforce by April, looking for buyers
    Yumanity to cut 60% of workforce by April, looking for buyers

    https://www.fiercebiotech.com/biotech/yumanity-cut-60-its-workforce-april-looking-buyers

    Max Bayer FIERCEBIOTECH
    18 Feb 2022
    Share Share
    Yumanity Tx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Yumanity Tx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2022/02/04/2379532/0/en/Yumanity-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    04 Feb 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search